During the last session, Fusion Pharmaceuticals Inc (NASDAQ:FUSN)’s traded shares were 4.51 million, with the beta value of the company hitting -0.71. At the end
In the last trading session, 1.56 million shares of the Fusion Pharmaceuticals Inc (NASDAQ:FUSN) were traded, and its beta was -0.73. Most recently the company’s
Fusion Pharmaceuticals Inc (NASDAQ:FUSN)’s traded shares stood at 1.64 million during the last session, with the company’s beta value hitting -0.79. At the close of
In the latest trading session, 0.65 million Fusion Pharmaceuticals Inc (NASDAQ:FUSN) shares changed hands as the company’s beta touched -0.75. With the company’s most recent
In recent trading session, Fusion Pharmaceuticals Inc (NASDAQ:FUSN) saw 0.97 million shares changing hands at last check today with its beta currently measuring -0.74. Company’s
Fusion Pharmaceuticals Inc (NASDAQ:FUSN) has a beta value of -0.85 and has seen 41.24 million shares traded in the last trading session. The company, currently
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
